tinnitus

Altamira finds buyer for Zilentin inner ear unit so Swiss biotech can go all-in on RNA
Fierce Biotech
Sun, 10/23/22 - 06:54 pm
Altamira Therapeutics
Zilentin
R&D
biobucks
hearing loss
tinnitus
0-for-3 in PhIII: Auris’ late-stage changeup fails to save tinnitus drug from another disaster
Endpoints
Tue, 03/13/18 - 09:36 pm
Auris
tinnitus
clinical trials
Keyzilen
AM-101
Strike two: Auris shares crushed again as its second PhIII program fails to deliver
Endpoints
Tue, 11/28/17 - 10:57 am
Auris Medical
AM-111
hearing loss
tinnitus
Google’s data-crunching mavens at GV buy in to Decibel’s R&D program for hearing loss, tinnitus
Endpoints
Thu, 07/6/17 - 09:45 am
Google Ventures
Decibel Therapeutics
hearing loss
tinnitus
R&D
Auris shares are crushed as tinnitus drug fails PhIII test
Endpoints
Thu, 08/18/16 - 09:01 am
Auris
tinnitus
clinical trials
Keyzilen
AM-101
Otonomy heads to the clinic with a tinnitus drug
Fierce Biotech
Mon, 10/5/15 - 05:53 pm
Otonomy
tinnitus
FDA
OTO-311
Medical Device Company MicroTransponder Presents Positive Tinnitus Clinical Trial Results at Tinnitus Research Institute Conference in Europe
Thu, 07/5/12 - 07:48 pm
tinnitus
MicroTransponder
vagus nerve stimulation
Serenity System
Ohio U. spinoff Sanuthera developing iPod-like tinnitus therapy device
Wed, 05/11/11 - 05:01 pm
tinnitus
Ohio
therapy